Oruka Therapeutics (ORKA) Stock Research

Today

Oruka Therapeutics reports Q2 EPS (55c), consensus (50c)

ORKA

7:22 AM

Over a week ago

Oruka Therapeutics falls -8.1%

ORKA

Jul 2, 10:00 AM

Oruka Therapeutics price target raised by $30 at UBS, here's why

ORKA

Jul 1, 7:08 AM

BTIG says others may be interested in Apogee Therapeutics

Jun 22, 6:34 AM

Oruka Therapeutics reports Q1 EPS (48c), consensus (54c)

ORKA

May 13, 4:28 PM

Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis

May 6, 8:15 AM

Oruka Therapeutics price target raised by $11 at Leerink

ORKA

Apr 30, 6:04 AM

Oruka Therapeutics price target raised by $45 at H.C. Wainwright, here's why

ORKA

Apr 29, 6:12 AM

Oruka Therapeutics $700M Secondary priced at $72.50

ORKA

Apr 28, 7:45 PM

Oruka Therapeutics price target raised by $25 at UBS, here's why

ORKA

Apr 28, 8:07 AM

Oruka Therapeutics announces $500M common stock, warrants offering

ORKA

Apr 27, 4:18 PM

Oruka Therapeutics price target raised by $60 at Clear Street, here's why

ORKA

Apr 27, 4:08 PM

Oruka Therapeutics rises 19.0%

ORKA

Apr 27, 12:01 PM

Oruka Therapeutics price target raised by $80 at Wedbush, here's why

ORKA

Apr 27, 11:40 AM

Oruka Therapeutics price target raised by $82 at Barclays, here's why

ORKA

Apr 27, 11:40 AM

Oruka Therapeutics price target raised by $75 at Guggenheim, here's why

ORKA

Apr 27, 11:28 AM

Oruka Therapeutics price target raised by $73 at BTIG, here's why

ORKA

Apr 27, 10:13 AM

Oruka Therapeutics rises 23.5%

ORKA

Apr 27, 10:00 AM

Morning Movers: Domino's Pizza sinks following first quarter results

Apr 27, 8:53 AM

Oruka Therapeutics announces interim results from EVERLAST-A trial

ORKA

Apr 27, 8:18 AM

Oruka Therapeutics price target raised by $40 at Wedbush, here's why

ORKA

Apr 15, 7:44 AM

Leerink sees Spyre's SPY001 Phase 2 Data as incrementally positive for Oruka

Apr 13, 2:32 PM

Oruka Therapeutics price target raised by $5 at BTIG, here's why

ORKA

Apr 13, 7:42 AM

Oruka Therapeutics price target raised by $30 at H.C. Wainwright, here's why

ORKA

Apr 13, 6:10 AM

Oruka Therapeutics price target raised by $28 at Barclays, here's why

ORKA

Apr 7, 6:20 AM

Today

Oruka Therapeutics reports Q2 EPS (55c), consensus (50c)

ORKA

7:22 AM

Over a week ago

Oruka Therapeutics falls -8.1%

ORKA

Jul 2, 10:00 AM

Oruka Therapeutics price target raised by $30 at UBS, here's why

ORKA

Jul 1, 7:08 AM

BTIG says others may be interested in Apogee Therapeutics

Jun 22, 6:34 AM

Oruka Therapeutics reports Q1 EPS (48c), consensus (54c)

ORKA

May 13, 4:28 PM

Halozyme licenses Hypercon technology to Oruka Therapeutics in psoriasis

May 6, 8:15 AM

Oruka Therapeutics price target raised by $11 at Leerink

ORKA

Apr 30, 6:04 AM

Oruka Therapeutics price target raised by $45 at H.C. Wainwright, here's why

ORKA

Apr 29, 6:12 AM

Oruka Therapeutics $700M Secondary priced at $72.50

ORKA

Apr 28, 7:45 PM

Oruka Therapeutics price target raised by $25 at UBS, here's why

ORKA

Apr 28, 8:07 AM

Oruka Therapeutics announces $500M common stock, warrants offering

ORKA

Apr 27, 4:18 PM

Oruka Therapeutics price target raised by $60 at Clear Street, here's why

ORKA

Apr 27, 4:08 PM

Oruka Therapeutics rises 19.0%

ORKA

Apr 27, 12:01 PM

Oruka Therapeutics price target raised by $80 at Wedbush, here's why

ORKA

Apr 27, 11:40 AM

Oruka Therapeutics price target raised by $82 at Barclays, here's why

ORKA

Apr 27, 11:40 AM

Oruka Therapeutics price target raised by $75 at Guggenheim, here's why

ORKA

Apr 27, 11:28 AM

Oruka Therapeutics price target raised by $73 at BTIG, here's why

ORKA

Apr 27, 10:13 AM

Oruka Therapeutics rises 23.5%

ORKA

Apr 27, 10:00 AM

Morning Movers: Domino's Pizza sinks following first quarter results

Apr 27, 8:53 AM

Oruka Therapeutics announces interim results from EVERLAST-A trial

ORKA

Apr 27, 8:18 AM

Oruka Therapeutics price target raised by $40 at Wedbush, here's why

ORKA

Apr 15, 7:44 AM

Leerink sees Spyre's SPY001 Phase 2 Data as incrementally positive for Oruka

Apr 13, 2:32 PM

Oruka Therapeutics price target raised by $5 at BTIG, here's why

ORKA

Apr 13, 7:42 AM

Oruka Therapeutics price target raised by $30 at H.C. Wainwright, here's why

ORKA

Apr 13, 6:10 AM

Oruka Therapeutics price target raised by $28 at Barclays, here's why

ORKA

Apr 7, 6:20 AM

Company News

Charts